1108P Outcomes when stage IV non-small cell lung cancer (NSCLC-4) patients (pts) harboring oncogenic drivers (OD) are treated initially without tyrosine kinase inhibitors (TKI) Proceedings (Faculty180)

cited authors

  • Choksi, R.; Smith, R.; Johnson, M.; Gordan, L.; Xue, M.; Varughese, P.; Dorrow, N.; Wang, B.; Vaidya, V.; Vasudevan, A.; Gart, M.; Gierman, H.; Scott, J.

authors

publication date

  • 2022

presented at event

start page

  • S1057

end page

  • S1058

volume

  • 33